Whereas HIF-1 inhibition during radiotherapy may decrease the growth rate of surviving tumor cells influencing growth delay, it may not induce killing of tumor stem cells to an extent detectable as improved local tumor control. This evidence concerns the gene HIF1A and neoplasm.